Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apellis Pharmaceuticals (APLS) Net Income (2020 - 2025)

Apellis Pharmaceuticals filings provide 6 years of Net Income readings, the most recent being -$59.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Net Income fell 142.82% year-over-year to -$59.0 million, compared with a TTM value of $22.4 million through Dec 2025, up 193.62%, and an annual FY2025 reading of $22.4 million, up 193.82% over the prior year.
  • Net Income hit -$59.0 million in Q4 2025 for Apellis Pharmaceuticals, down from $215.7 million in the prior quarter.
  • The five-year high for Net Income was $283.4 million in Q4 2021, with the low at -$219.2 million in Q2 2021.
  • Median Net Income over the past 5 years was -$87.7 million (2022), compared with a mean of -$68.3 million.
  • The largest YoY upside for Net Income was 475.52% in 2025 against a maximum downside of 142.82% in 2025.
  • Year by year, Net Income stood at $283.4 million in 2021, then plummeted by 129.35% to -$83.2 million in 2022, then soared by 51.8% to -$40.1 million in 2023, then surged by 443.38% to $137.7 million in 2024, then plummeted by 142.82% to -$59.0 million in 2025.
  • According to Business Quant data, Net Income over the past three periods came in at -$59.0 million, $215.7 million, and -$42.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.